Imunon IMNN
NASDAQ IMNN
$1.34 -0.04 (-3.26%)
At close: Sep 29, 2026 · 4:00 PM EDT

Imunon (IMNN) Restructuring Costs (2014)

Updated

Imunon (IMNN) posted Restructuring Costs of $198,000 for Q4 2014, up 65.0% from the prior quarter.

Analysis

Imunon (IMNN) Restructuring Costs (2014) Analysis & Trends

For FY2014, Imunon's Restructuring Costs came in at $1.39 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Imunon 6.44 Mn 6.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 198,000.00
Sep 30, 2014 119,996.00
Jun 30, 2014 1.07 Mn
API Access

Imunon Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=IMNN&period=max&api_key=YOUR_API_KEY